HTA and cell and gene remedy – Healthcare Economist
A paper by Drummond et al. (2023) examines how Health Technology evaluation our bodies cope with the problem of worth evaluation for cell and gene therapies (often known as Superior Remedy Medicinal Merchandise (ATMPs) in Europe). To do that the authors: …undertook i) a focused overview of the literature on […]
HTA and cell and gene remedy – Healthcare Economist Read More »









